Adheris Health Ltd (ASX: AHE) Share Price and News

Price

 

Movement

   

  (20 mins delayed)

52 Week Range

  -  

 
1 Year Return

 

Adheris Health Ltd Chart and Price Data

Fundamentals Data provided by Morningstar.

Data provided by Morningstar.
Market Cap $12.75 million
P/E Ratio 107.69
Dividend Yield 0.00%
Shares Outstanding 637.68 million
Earnings per share -0.103
Dividend per share N/A
Year To Date Return N/A
Earnings Yield 0.93%
Franking -
Share Price

Day Change

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

as at 24 Feb 3:44pm

  • Adheris Health Ltd (ASX: AHE)
    Latest News

    a woman
    Share Gainers

    MedAdvisor share price rockets 15% higher on UK update

    The MedAdvisor Ltd (ASX:MDR) share price is rocketing higher on Tuesday morning after providing an update on its UK operations...

    Read more »

    a woman
    Share Market News

    Here's why this ASX medical tech share surged 14% today

    The Medadvisor Ltd (ASX:MDR) share price surged 13.92% higher today after the company released its half-year FY20 results.

    Read more »

    a woman
    Share Market News

    Why these 3 ASX shares slumped lower today

    With the S&P/ASX 200 Index (INDEXASX: XJO) trading higher today, let's take a look at why these 3 ASX shares fared…

    Read more »

    a woman
    Share Market News

    3 ASX medical tech shares surging higher today

    Here are 3 ASX shares in the fast-growing medical tech sector that have seen gains of around 5% so far…

    Read more »

    a woman
    Share Gainers

    Medadvisor share price rockets 28% higher on U.S. update

    The Medadvisor Ltd (ASX:MDR) share price was one of the best performers on the Australian share market on Thursday...

    Read more »

    a woman
    Share Market News

    SaaS player MedAdvisor Ltd raises $17 million for growth push

    MedAdvisor is a little-known tech and healthcare small cap.

    Read more »

    a woman
    ⏸️ Investing

    Why the MedAdvisor Ltd (ASX:MDR) share price is up 20% today

    MedAdvisor Ltd (ASX:MDR) jumps 20% to 4.8 cents in morning trade following the announcement that it has signed a Co-Marketing and Licence…

    Read more »

    a woman
    ⏸️ Investing

    These tech shares are flying

    These three tech shares are making investors happy…

    Read more »

    a woman
    ⏸️ Investing

    3 Exciting Med-Tech Stocks For Asthma: Are They Any Good?

    Technology to treat chronic disease can be very profitable, but that doesn't mean every company that aims to treat chronic…

    Read more »

    AHE ASX Announcements

    An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

    DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
    YesNo

    About Adheris Health Ltd

    MedAdvisor Ltd. engages in the provision of mobile and web software platform for prescription medication use. It operates through the following segments: MedAdvisor and Corporate. The MedAdvisor segment includes medication management and adherence platform. The Corporate segment comprises of the company's function associated with being an ASX listed company. MedAdvisor was founded by Joshua Swinnerton in 2010 and is headquartered in Camberwell, Australia.

    AHE Share Price History Data provided by Morningstar.

    Data provided by Morningstar.
    Date Close Change % Change Volume Open High Low
    24 Apr 2026 $0.02 $0.00 0.00% 116,401 $0.02 $0.02 $0.02
    23 Apr 2026 $0.02 $0.00 0.00% 264,454 $0.02 $0.02 $0.02
    22 Apr 2026 $0.02 $0.00 0.00% 455,251 $0.02 $0.02 $0.02
    21 Apr 2026 $0.02 $0.00 0.00% 269,799 $0.02 $0.02 $0.02
    20 Apr 2026 $0.02 $0.00 0.00% 9,755 $0.02 $0.02 $0.02
    17 Apr 2026 $0.02 $0.00 0.00% 180,428 $0.02 $0.02 $0.02
    16 Apr 2026 $0.02 $0.00 0.00% 51,639 $0.02 $0.02 $0.02
    15 Apr 2026 $0.02 $0.00 0.00% 479,172 $0.02 $0.02 $0.02
    14 Apr 2026 $0.02 $0.00 0.00% 100,000 $0.02 $0.02 $0.02
    13 Apr 2026 $0.02 $0.00 0.00% 290,126 $0.02 $0.02 $0.02
    10 Apr 2026 $0.02 $0.00 0.00% 1,373,469 $0.02 $0.02 $0.02
    09 Apr 2026 $0.02 $0.00 0.00% 248,550 $0.02 $0.02 $0.02
    08 Apr 2026 $0.02 $0.00 0.00% 76,255 $0.02 $0.02 $0.02
    07 Apr 2026 $0.02 $0.00 0.00% 20,870 $0.02 $0.02 $0.02
    02 Apr 2026 $0.02 $0.00 0.00% 73,292 $0.02 $0.02 $0.02
    01 Apr 2026 $0.02 $0.00 0.00% 25,250 $0.02 $0.02 $0.02
    31 Mar 2026 $0.02 $0.00 0.00% 170,224 $0.02 $0.02 $0.02
    30 Mar 2026 $0.02 $0.00 0.00% 193,816 $0.02 $0.02 $0.02
    27 Mar 2026 $0.02 $0.00 0.00% 264,604 $0.02 $0.02 $0.02
    26 Mar 2026 $0.02 $0.00 0.00% 2,500 $0.02 $0.02 $0.02

    Director Transactions Data provided by Morningstar.

    Data provided by Morningstar.
    Date Director Type Amount Value Notes
    10 Apr 2026 John Ciccio Issued 30,000,000 $540,000
    Issue of options.
    09 Mar 2026 Lucas Merrow Buy 695,000 $15,116
    On-market trade. Average price
    03 Mar 2026 Lucas Merrow Buy 890,000 $19,580
    On-market trade. Average price
    02 Mar 2026 Catherine (Kate) Hill Buy 1,500,000 $30,000
    On-market trade. Average price
    06 Nov 2025 Lucas Merrow Issued 500,000 $50,000
    Placement.
    06 Nov 2025 Catherine (Kate) Hill Issued 500,000 $50,000
    Placement.

    Directors & Management Data provided by Morningstar.

    Data provided by Morningstar.
    Name Title Start Date Profile
    Ms Catherine (Kate) Jane Hill Non-Executive DirectorInterim Chairman May 2023
    Ms Hill is an experienced auditor and business advisor with over 30 years of experience of working with privately owned companies across a range of business issues. She is an experienced director of small- to mid-cap companies listed on global exchanges, with a record in creating change involving new business models, new markets and new technologies. She is a Member of People Committee and Chair of Risk Committee.
    Mr Sean Slattery Chief Financial OfficerExecutive Director Jul 2025
    Mr Slattery is a finance executive who has worked with med-tech ASX listed companies with US operations, recently Rhinomed (ASX:RNO) ahead of its recent sale.
    Mr Lucas Merrow Non-Executive Director Aug 2021
    Mr Merrow co-founded and served as the CEO of Eliza Corporation- health engagement management and patient communications. Eliza Corporation was later acquired. Prior to the founding of Eliza Corporation, Lucas co-founded and served as the COO of Adheris Health, a firm in prescription adherence and patient education programs in the United States. He is a Member of People Committee
    Mr John Ciccio Chief Executive OfficerManaging Director Nov 2025
    --
    Mr Lee Tamplin Company Secretary Apr 2026
    -
    Ancila Desai Chief Financial Officer
    -
    Lee Tamplin Company Secretary
    -

    Top Shareholders Data provided by Morningstar.

    Data provided by Morningstar.
    Name Shares Capital
    HSBC Custody Nominees (Australia) Limited 106,641,679 17.07%
    Guild Group Holdings Limited 94,905,130 15.19%
    J P Morgan Nominees Australia Pty Limited 59,815,291 9.57%
    Ebos Ph Pty Ltd 53,986,823 8.64%
    Cotiviti Inc 43,999,999 7.04%
    Citicorp Nominees Pty Limited 31,610,031 5.06%
    Bond Street Custodians Limited (Salter D79836 A/C) 27,550,000 4.41%
    BNP Paribas Nominees Pty Ltd (Ib Au Noms Retailclient) 16,278,900 2.61%
    Indcorp Consulting Group Pty Limited (Superannuation Fund A/C) 7,145,000 1.14%
    Kojent Pty Ltd (Kojent A/C) 6,846,956 1.10%
    Romida Enterprises Pty Ltd (Romida Family A/C) 5,642,935 0.90%
    Gread Management Pty Limited (The A G & R R Family A/C) 5,344,283 0.86%
    Tagdime Pty Ltd (Ian M Davison P/L S/F A/C) 4,331,854 0.69%
    Dr Christopher Harold Benton 4,215,000 0.67%
    Provare Pty Ltd (Provare Investment A/C) 3,743,419 0.60%
    Dmx Capital Partners Limited i 2,500,000 0.40%
    Dmx Capital Partners Limited 2,434,351 0.39%
    Celerity Investments Pty Limited 2,348,978 0.38%
    Hylec Controls Pty Ltd 2,300,000 0.37%
    Hylec Investments Pty Limited (Hylec Controls P/L S/F A/C) 2,300,000 0.37%

    Profile

    since

    Note